Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002099)

Reversed phase POSITIVE ION MODE (Analysis AN003430)

Metabolite	Structure	F1	F2	F3	F4	F5	F6
Aminoadipic acid	ME510894	1.12	0.99	1.05	0.76	1.25	0.84
Creatine	ME510882	0.90	1.40	0.86	1.93	0.59	0.33
Deoxycytidine	ME510857	0.54	1.91	0.53	1.65	0.72	0.65
Inosine	ME510885	0.99	1.59	1.18	1.06	0.74	0.44
Cytosine	ME510886	0.61	1.20	0.53	1.13	1.06	1.46
2^-Deoxycytidine 5^-monophosphate	ME510879	0.52	0.92	0.70	0.38	1.52	1.96
5-aminosalicylic acid	ME510873	0.74	1.40	0.69	0.91	1.22	1.03
Betaine	ME510866	0.70	2.00	0.70	1.15	0.89	0.55
Guanosine 5^-monophosphate	ME510887	0.49	1.12	0.76	0.35	1.07	2.20
2-Deoxyguanosine	ME510856	0.71	1.39	0.82	1.38	0.85	0.85
Guanidineacetic acid	ME510841	0.72	1.97	0.62	1.55	0.67	0.47
Dopamine	ME510858	0.77	1.45	0.64	0.80	1.41	0.92
Hypoxanthine	ME510883	0.87	1.57	1.16	0.83	0.84	0.73
his	ME510849	0.84	1.43	0.84	1.28	1.00	0.62
2^-Deoxyguanosine 5^-monophosphate	ME510878	0.30	0.57	0.63	0.18	1.51	2.82
2,4-Diaminobutyric acid	ME510830	0.44	2.97	0.41	1.20	0.55	0.43
Cytidine	ME510864	0.65	1.69	0.61	1.21	1.04	0.81
Adenosine	ME510863	0.45	1.94	0.81	0.83	1.16	0.80
Choline	ME510881	1.02	1.41	0.84	1.29	0.93	0.52
Acetylcholine	ME510834	0.64	1.04	0.81	0.81	1.53	1.17
2-Aminoimidazole	ME510833	0.72	1.46	0.89	1.00	1.04	0.90
2^-Deoxyuridine	ME510853	0.76	1.63	0.65	1.40	0.88	0.69
3-Guanidinopropionic acid?	ME510874	0.56	2.29	0.73	0.89	0.97	0.56
L-Homoserine	ME510832	0.82	1.60	0.66	1.36	0.98	0.58
Acetylcarnitine	ME510876	1.25	1.29	0.69	2.01	0.53	0.24
Biotin	ME510862	1.06	1.44	0.70	0.55	1.15	1.10
L-Glutamine	ME510896	0.82	1.70	0.64	1.40	0.86	0.57
Indole-3-acetic acid	ME510867	0.93	1.89	0.87	0.86	0.96	0.48
L-Citrulline	ME510836	0.83	1.30	0.76	0.86	1.31	0.94
L-Arginine	ME510869	0.75	2.15	0.49	1.88	0.49	0.25
L-Carnitine hydrochloride	ME510872	1.14	1.46	0.78	1.16	0.89	0.56
5-Methylcytidine	ME510840	0.99	1.69	0.79	1.28	0.78	0.46
Isonicotinic acid	ME510859	0.82	1.53	1.04	0.79	1.11	0.71
Histamine	ME510868	0.65	1.58	0.54	1.36	0.96	0.92
Isoleucine	ME510831	0.86	1.84	0.70	1.33	0.75	0.52
Alanine	ME510888	0.87	1.60	0.70	1.31	0.98	0.54
Beta-Sitosterol	ME510852	0.93	1.54	0.57	1.08	1.13	0.75
Cytidine monophosphate	ME510861	0.56	1.28	0.83	0.61	1.22	1.50
6-Aminocaproic acid	ME510851	0.94	1.28	0.91	1.50	0.80	0.57
2-Deoxyadenosine	ME510860	0.44	2.05	0.66	0.74	1.20	0.91
L-Glutamate	ME510848	0.75	1.49	0.76	0.78	1.24	0.99

Factors:

F1	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil)
F2	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil)
F3	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil)
F4	Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil)
F5	Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.
F6	Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil.

Data matrix